Image

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Investigating Safety and Effectiveness of Investigational Treatment for Metastatic Pancreatic Cancer

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic pancreatic cancer. The purpose of this study is to evaluate the safety and effectiveness of a combination treatment that includes nab-paclitaxel, gemcitabine, and an amplitude-modulated radiofrequency electromagnetic fields device.

The study evaluates whether this combination treatment is safe and effective for patients. It looks into how well patients tolerate the treatment and any effects it may have on their condition.

  • Who can participate: Adults over 18 years with advanced metastatic pancreatic cancer can participate. Participants must have measurable tumors and meet specific health criteria.
  • Study details: Participants will receive a combination of treatments that include nab-paclitaxel, gemcitabine, and a device that uses electromagnetic fields. A placebo is not used in this study.
Print
Study details
    Metastatic Pancreatic Adenocarcinoma

NCT06576115

Barbara Ann Karmanos Cancer Institute

15 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.